Posts

Showing posts from June, 2019

Benefits of a market subscription on single report buying

Image
Market Research is a service provided to help companies with market analysis and statistics to facilitate their easy growth in this fast-evolving world. However, Subscription-based market research services provided by PharmDelve are a cost-effective alternative to individual report buying. Since market research subscription not only covers a vast area of data but also saves time and money of the client by providing exhaustive research and coverage of all the required data for any indication.  Some of the key benefits of purchasing market research report subscription service are listed below.  1. Access to the vast repository platform of the company. Prior to buying reports, the exact information on the report is not disclosed. Afterwards, many a time, clients feel that the report purchased is not sufficient or detailed enough to address all the queries associated. Then, the need to make an extra purchase arises. However, with the help of Subscription-based Market resear

Neuroendocrine Tumor Market

Neuroendocrine tumors are rare. However, during past decade NETs incidence is on a rise.  DelveInsight’s   ‘ Neuroendocrine Tumors Market Insights, Epidemiology and Market Forecast — 2027 ’   provide insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders.  DelveInsight’s estimates show that the total Neuroendocrine Tumor prevalent population in 7 Major Markets was 4, 42,100 and total NET incident cases were 44,070 in 2016. United States reported higher NET prevalence with 1, 93,877 cases in 2016, followed by EU5 and Japan. Among EU5, Germany had the highest prevalent population of NETwhile Spain had the lowest. NET is known to affect males more predominant as compared to females. The report provides historical as well as forecasted  Neuroendocrine Tumors  epidemiology,  Neuroendocrine Tumors  prevalent cases, sym

Pompe Disease Market

Image
Pompe Disease Market Insights, Epidemiology and MarketForecast-2028 report by DelveInsight provides an in-depth understanding of the disease, historical & forecasted epidemiology as well as Pompe Disease market trends in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom), and Japan. Pompe disease, also known as glycogen storage disease type II [GSDII], acid maltase deficiency or GAA deficiency), an autosomal recessive inherited disorder caused by a mutation in the GAA gene. GAA Deficiency affects lysosomal-mediated degradation of glycogenesis and leads to intralysosomal glycogen accumulation and disruption of the tissue architecture in various organs, like in skeletal muscles, heart and liver. Pompe disease epidemiology Pompe Disease epidemiology division proffers the insights about historical and current patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by